Articles with public access mandates - Phuoc T. Tran, MD, PhDLearn more
Not available anywhere: 18
A systematic review of the evidence for the decipher genomic classifier in prostate cancer
NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ...
European urology 79 (3), 374-383, 2021
Mandates: US Department of Defense
Survival and death signals can predict tumor response to therapy after oncogene inactivation
PT Tran, PK Bendapudi, HJ Lin, P Choi, S Koh, J Chen, G Horng, ...
Science translational medicine 3 (103), 103ra99-103ra99, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Tissue-and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer: a systematic review
K Van der Eecken, J Vanwelkenhuyzen, MP Deek, PT Tran, E Warner, ...
European Urology Oncology 4 (6), 914-923, 2021
Mandates: US National Institutes of Health
Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: A survey …
MP Huynh-Le, Z Zhang, PT Tran, TL DeWeese, DY Song
International Journal of Radiation Oncology* Biology* Physics 90 (5), 1076-1082, 2014
Mandates: US National Institutes of Health
Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer
NR Parikh, EM Chang, NG Nickols, MB Rettig, AC Raldow, ML Steinberg, ...
International Journal of Radiation Oncology* Biology* Physics 108 (4), 917-926, 2020
Mandates: US National Institutes of Health
Metastasis-directed therapy in prostate cancer: Why, when, and how?
RM Phillips, MP Deek, TL DeWeese, PT Tran
Oncology (08909091) 33 (10), 2019
Mandates: US National Institutes of Health
Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations
RM Phillips, C Lam, H Wang, PT Tran
Advances in cancer research 142, 23-62, 2019
Mandates: US National Institutes of Health
Twist1 is required for the development of UVB‐induced squamous cell carcinoma
F Eguiarte‐Solomon, N Blazanin, O Rho, S Carbajal, DW Felsher, ...
Molecular Carcinogenesis 60 (5), 342-353, 2021
Mandates: Cancer Prevention Research Institute of Texas, USA
Adjuvant radiation for node-positive disease after prostatectomy: More good news, but who will listen?
PT Tran, TJ Bivalacqua, AP Dicker
Journal of Clinical Oncology 32 (35), 3917-3919, 2014
Mandates: US National Institutes of Health
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
SA Patel, TM Ma, JK Wong, BJ Stish, RT Dess, A Pilar, C Reddy, ...
International Journal of Radiation Oncology* Biology* Physics 115 (3), 645-653, 2023
Mandates: US National Institutes of Health
The impact of salvage radiotherapy initiation at PSA≤ 0.5 ng/ml on metastasis‐free survival in patients with relapsed prostate cancer following prostatectomy
EE Lee, T Singh, C Hu, M Han, CJ Deville, A Halthore, S Greco, P Tran, ...
The Prostate 83 (2), 190-197, 2023
Mandates: US Department of Defense, US National Institutes of Health
Implementing survivorship care planning in two contrasting health systems: lessons learned from a randomized controlled trial
KC Smith, S White, J DeSanto, S Hannum, N Mayonado, N Ahuja, ...
Journal of Cancer Survivorship 16 (4), 791-800, 2022
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
What are survivorship care plans failing to tell men after prostate cancer treatment?
Y Choi, KC Smith, A Shukla, AL Blackford, PT Tran, KS Peairs, ...
The Prostate 81 (7), 398-406, 2021
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
From Idea to Clinical Practice: A Brief History of Oligometastatic Disease
PT Tran, P Sutera, RM Phillips, MP Deek, S Chmura
International Journal of Radiation Oncology, Biology, Physics 114 (4), 576-580, 2022
Mandates: US Department of Defense, US National Institutes of Health
Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer—Not All That Glitters Is Gold—Reply
PT Tran, MP Deek, RM Phillips
JAMA oncology 6 (10), 1639-1639, 2020
Mandates: US National Institutes of Health
Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate‐risk prostate cancer at high risk of distant recurrence and …
J Hayman, R Phillips, D Chen, J Perin, AK Narang, J Trieu, N Radwan, ...
The Prostate 78 (8), 623-630, 2018
Mandates: US National Institutes of Health
Live to SABR another day?
PT Tran, F Feng, P Ost
International journal of radiation oncology, biology, physics 100 (5), 1097, 2018
Mandates: US National Institutes of Health
Reply to CG Rusthoven et al
PT Tran, TJ Bivalacqua, AP Dicker
Journal of Clinical Oncology 33 (17), 1990-1991, 2015
Mandates: US National Institutes of Health
Available somewhere: 142
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas
J Zeng, AP See, J Phallen, CM Jackson, Z Belcaid, J Ruzevick, N Durham, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 343-349, 2013
Mandates: US National Institutes of Health
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program